Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.5.4 (
SOR
)
720
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several interventions may reduce the risk of contrast nephropathy for high-risk patients; however, most evidence uses surrogate markers for clinically relevant outcomes. Because dehydration is a risk factor for developing contrast nephropathy, periprocedural hydration is routinely recommended (strength of recommendation [
SOR
]: C, expert opinion). Single studies have suggested that isotonic saline is associated with less risk than half-normal saline, and hydration with fluids containing sodium bicarbonate is more efficacious than those containing isotonic saline (
SOR
: B, single randomized controlled trial [RCT]). Oral acetylcysteine lowers the risk of postcontrast elevations in creatinine if taken more than 24 hours before contrast administration (
SOR
: A, RCTs). Acetylcysteine's low cost and favorable side effect profile make it an appealing option.
Hypo
-osmolar contrast media are less likely to induce contrast nephropathy than hyper-osmolar media (
SOR
: A, RCTs). Finally, hemofiltration might be considered for patients with extremely high risk of developing contrast nephropathy (
SOR
: B, single RCT).
...
PMID:Clinical inquiries. What interventions reduce the risk of contrast nephropathy for high-risk patients? 1583 30